Nicotinic acid (NA\; niacin) is converted by nicotinic acid phosphoribosyltransferase (NAPRT\; EC 2.4.2.11) to NA mononucleotide (NaMN), which is then converted to NA adenine dinucleotide (NaAD), and finally to nicotinamide adenine dinucleotide (NAD), which serves as a coenzyme in cellular redox reactions and is an essential component of a variety of processes in cellular metabolism including response to stress (Hara et al., 2007).[supplied by OMIM, Mar 2008].
Shames, Elkins, Walter, Holcomb, Du, Mohl, Xiao, Pham, Haverty, Liederer, Liang, Yauch, OBrien, Bourgon, Koeppen, Belmont: "Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 24, pp. 6912-23, (2013) (PubMed).
Xiao, Elkins, Durieux, Lee, Oeh, Yang, Liang, DelNagro, Tremayne, Kwong, Liederer, Jackson, Belmont, Sampath, OBrien: "Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618." in: Neoplasia (New York, N.Y.), Vol. 15, Issue 10, pp. 1151-60, (2013) (PubMed).
Fagerberg, Stadler, Skogs, Hjelmare, Jonasson, Wiking, Abergh, Uhlén, Lundberg: "Mapping the subcellular protein distribution in three human cell lines." in: Journal of proteome research, Vol. 10, Issue 8, pp. 3766-77, (2011) (PubMed).